References
- Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994; 23(3): 437–55
- Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981; 2(8256): 1129–33
- Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 1991; 11(2): 73–83
- Hoofhagle JH, Shalritz DA, Popper H. Chronic type B hepatitis and the healthy HBsAg carrier state. Hepatology 1987; 7(4): 758–63
- Bonino F, Rosina F, Rizzetto M, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90(5 Pt 1): 1268–73
- Perrillo RP, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon alfa- 2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323(5): 295–301
- Wong DK, Cheung AM, O'Rourke K, et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993: 119(4): 312–23
- Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40(RR-13): l-25
- Di Bisceglie AM, Rustgi VK, Hoofnagle JH, et al. NIH conference: hepatocellular carcinoma. Ann Intern Med 1988; 108(3): 390–401